Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits

19 Aug 2019

Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.

Acquiring in July a basket of six OTC brands from GlaxoSmithKline PLC has not sated Stada Arzneimittel AG’s appetite for further deals to grow its consumer health-focused Branded Products division.

The Germany-based firm told HBW Insight that it was “continuously evaluating OTC acquisitions” in line with its strategy of “rapid...